tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
GLUE
Monte Rosa Therapeutics
RESEARCH TOOLSreports

Monte Rosa Therapeutics (GLUE) Stock News & Sentiment

Compare
357 Followers
Monte Rosa Therapeutics Prices $300 Million Public Offering
Premium
Company Announcements
Monte Rosa Therapeutics Prices $300 Million Public Offering
1d ago
8K
GLUE
Monte Rosa Therapeutics Ends Current ATM Equity Program
Premium
Company Announcements
Monte Rosa Therapeutics Ends Current ATM Equity Program
3d ago
8K
GLUE
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
3d ago
AAL
AMD
Here’s Why Monte Rosa Therapeutics Stock (GLUE) Rocketed Today
Premium
Market News
Here’s Why Monte Rosa Therapeutics Stock (GLUE) Rocketed Today
4d ago
GLUE
Monte Rosa Therapeutics: Early MRT-8102 hsCRP Data Underscore Differentiated NLRP3 Opportunity and Attractive Risk-Reward Supporting Buy Rating
Premium
Ratings
Monte Rosa Therapeutics: Early MRT-8102 hsCRP Data Underscore Differentiated NLRP3 Opportunity and Attractive Risk-Reward Supporting Buy Rating
4d ago
GLUE
Monte Rosa reports positive Phase 1 data for MRT-8102
Premium
Company Announcements
Monte Rosa reports positive Phase 1 data for MRT-8102
4d ago
8K
GLUE
Monte Rosa Therapeutics: Promising Progress with MRT-2359 in Advanced Prostate Cancer
Premium
Ratings
Monte Rosa Therapeutics: Promising Progress with MRT-2359 in Advanced Prostate Cancer
25d ago
GLUE
More GLUE News >

GLUE News on the Web

Weekly Buzz: ScinoPharm Gets FDA Nod; GNLX's Olvi-Vec Shows Promise; GLUE's MRT-8102 Advances
rttnews
Neutral
Monte Rosa Therapeutics Secures $300 Million Through Underwritten Public Offering—What Does This Mean for GLUE?
Market Chameleon
Neutral
Monte Rosa Therapeutics Prices Underwritten Public Offering Of $300 Mln Of Shares
rttnews
Neutral
GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug
Zacks
Neutral
Monte Rosa Therapeutics (GLUE) is on the Move, Here's Why the Trend Could be Sustainable
Zacks
Bullish
GLUE’s $200 Million Public Offering Proposal Spotlights Bold Expansion Strategy
Market Chameleon
Neutral
Why Monte Rosa Therapeutics, Inc.’s (GLUE) Stock Is Up 8.03%
AAII
Neutral
Monte Rosa Therapeutics (GLUE) Upgraded to Strong Buy: Here's Why
Zacks
Bullish

News Score - Last 7 Days

Positive
GLUE
Sector Average
Media Buzz
This Week18 articles
Weekly Average6.25 articles
News Sentiment
This Week100%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GLUE’s Media Buzz Sentiment?
18 articles about GLUE were published this week. In an average week, 6.25 articles are published.
    What is GLUE’s weekly average amount of articles?
    In an average week, 6.25 articles about GLUE are published.
      What is GLUE’s News Sentiment?
      100% of articles about GLUE were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        RVMDRevolution Medicines
        KRYSKrystal Biotech
        GNPXGenprex
        REGNRegeneron
        ARDXArdelyx
        Showing the stocks with the most bullish news sentiment over the past week